BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10095244)

  • 21. Treatment of Lyme disease.
    Med Lett Drugs Ther; 2000 May; 42(1077):37-9. PubMed ID: 10825919
    [No Abstract]   [Full Text] [Related]  

  • 22. Lyme disease: uphill struggle.
    Abbott A
    Nature; 2006 Feb; 439(7076):524-5. PubMed ID: 16452949
    [No Abstract]   [Full Text] [Related]  

  • 23. Lyme disease.
    Hayes E
    Clin Evid; 2002 Jun; (7):652-64. PubMed ID: 12230693
    [No Abstract]   [Full Text] [Related]  

  • 24. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula.
    Nassal M; Skamel C; Kratz PA; Wallich R; Stehle T; Simon MM
    Eur J Immunol; 2005 Feb; 35(2):655-65. PubMed ID: 15668917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Who should receive the Lyme disease vaccine?
    Taege AJ
    Cleve Clin J Med; 2000 Apr; 67(4):239-40. PubMed ID: 10780094
    [No Abstract]   [Full Text] [Related]  

  • 26. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
    O'Connor TP; Esty KJ; Hanscom JL; Shields P; Philipp MT
    Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 months.
    Schoen RT; Sikand VK; Caldwell MC; Van Hoecke C; Gillet M; Buscarino C; Parenti DL
    Clin Ther; 2000 Mar; 22(3):315-25. PubMed ID: 10963286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lyme borreliosis--the most frequent vector-borne infection in Denmark].
    Lebech AM; Hansen K
    Ugeskr Laeger; 2004 Jun; 166(25):2431-3. PubMed ID: 15283107
    [No Abstract]   [Full Text] [Related]  

  • 29. Lyme arthritis: lessons learned and to be learned.
    Sigal LH
    Arthritis Rheum; 1999 Sep; 42(9):1809-12. PubMed ID: 10513793
    [No Abstract]   [Full Text] [Related]  

  • 30. Lyme disease vaccines.
    Gardner P
    Ann Intern Med; 1998 Oct; 129(7):583-5. PubMed ID: 9758582
    [No Abstract]   [Full Text] [Related]  

  • 31. Study highlights variation in Lyme disease presentation.
    Quirk M
    Lancet Infect Dis; 2002 May; 2(5):266. PubMed ID: 12062987
    [No Abstract]   [Full Text] [Related]  

  • 32. Resurrecting the 'yuppie vaccine'.
    Willyard C
    Nat Med; 2014 Jul; 20(7):698-701. PubMed ID: 24999936
    [No Abstract]   [Full Text] [Related]  

  • 33. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
    Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL
    J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
    Lovrich SD; Jobe DA; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A.
    Pal U; de Silva AM; Montgomery RR; Fish D; Anguita J; Anderson JF; Lobet Y; Fikrig E
    J Clin Invest; 2000 Aug; 106(4):561-9. PubMed ID: 10953031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Proteins without a hydrophobic core: structure and stability].
    Ohnishi S; Koide S
    Tanpakushitsu Kakusan Koso; 2000 Nov; 45(15):2502-10. PubMed ID: 11086410
    [No Abstract]   [Full Text] [Related]  

  • 37. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
    Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
    J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune complexes from serum of patients with lyme disease contain Borrelia burgdorferi antigen and antigen-specific antibodies: potential use for improved testing.
    Brunner M; Sigal LH
    J Infect Dis; 2000 Aug; 182(2):534-9. PubMed ID: 10915085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lyme disease vaccine: hopes and concerns].
    Kondrusik M; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T
    Pol Merkur Lekarski; 1999 Jun; 6(36):344-6. PubMed ID: 10481552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lyme disease vaccine.
    Health News; 1998 Jun; 4(8):7. PubMed ID: 9644514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.